|
Lancet Publishes SELECT Study of Biogen’s Daclizumab HYP, Biogen Says …
Benzinga Today Biogen Idec (NASDAQ: BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article in The Lancet. SELECT was a Phase 2b study designed to determine the efficacy … Market opening: Biogen Idec up after positive MS drug studyMarketWatch (blog) |
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of … – Financial Post
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of …Financial PostToday Biogen Idec (NASDAQ: BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article…
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of … – MarketWatch (press release)
The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of …MarketWatch (press release)Today Biogen Idec (NASDAQ:BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an on…
Siberian scientists test anti-ageing pills on themselves – Russia & India Report
|
Siberian scientists test anti-ageing pills on themselves
Russia & India Report Siberian scientists have tested newly-developed drugs for the treatment of liver cirrhosis – more widely known as ‘anti-ageing pills’ – on themselves, without waiting for the results of clinical trials. The developers said they’d noticed very positive … |
National Cancer Institution: Major steps taken on breast cancer and leukemia – Ahram Online
 Ahram Online |
National Cancer Institution: Major steps taken on breast cancer and leukemia
Ahram Online Kamal then moved on to explain that before 2000 there was no medication and the only option was a risky stem cell transplant. After 2000, came two generations of “targeted medication” — the first being a ray of hope, the second the chance of a cure. |
Rahul's speech impressive, he spoke from heart: India Inc – Zee News
 Zee News |
Rahul’s speech impressive, he spoke from heart: India Inc
Zee News Sam Pitroda, adviser to Prime Minister, also said, “I liked it. I think he spoke from his heart. He talked about inclusive growth and collaboration. I have worked with him. We have a very long relationship with Rajiv Gandhi and the family, and with … |
Rahul's speech impressive, he spoke from heart, India Inc says – Times of India
Zee News |
Rahul’s speech impressive, he spoke from heart, India Inc says
Times of India NEW DELHI: India Inc was impressed by Congress leader Rahul Gandhi’s maiden interaction with corporate leaders on Thursday saying he came across as a sincere leader and this can form the basis for future engagement with the industry. “It was a very … Rahul’s speech impressive, he spoke from heart: India IncZee News Rahuls Speech Impressive, He Spoke From Heart, India Inc SaysSiliconindia.com Gandhi says growth in ‘beehive’ India must help poorDAWN.com NDTV all 174 news articles » |
Rate of Nephrectomy at Lymph Node Dissection Is Declining – Renal and Urology News
Rate of Nephrectomy at Lymph Node Dissection Is DecliningRenal and Urology NewsOver the last 30 years, the incidence of nephrectomy at post-chemotherapy (PC) retroperitoneal lymph node dissection (RPLND) has steadily declined, according to research pub…
Anti-HIV Antibodies May Spur AIDS Vaccine Development – TIME
 TIME |
Anti-HIV Antibodies May Spur AIDS Vaccine Development
TIME From the moment of infection, the immune system goes on alert and immediately generates antibodies designed to attach to and destroy HIV. And for the first few weeks, these antibodies are successful, eliminating all but a few viruses that remain hidden … Antibodies ‘map’ to vaccine for AIDS foundThe Japan Times Breakthrough Reported in Creating Antibodies to Fight HIV/AIDSLatinos Post Findings on ‘Broadly Neutralizing Antibodies‘ May Be Key to HIV VaccineAIDSmeds.com HIV/AIDS Treatment News Bloomberg –Nature.com –Counsel & Heal all 38 news articles » |
Former England 'keeper sidelined with blood clot – Times of India
|
Former England ‘keeper sidelined with blood clot
Times of India LONDON: Former England goalkeeper Paul Robinson is set to be out for the rest of the season and well into the next after developing a blood clot on the lung, his club, English Championship side Blackburn Rovers, said. “Paul is set for a lengthy spell … |